Madrigal Pharmaceuticals Inc (MDGL) |
|
110.32 -3.67 (-3.22%)
|
06-03 16:00 |
|
Open: |
113.58 |
Pre. Close: |
113.99 |
|
High:
|
114.14 |
Low:
|
110.32 |
|
Volume:
|
93,909 |
Market Cap:
|
1,702M |
|
|
|
|
Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
114.463 - 115.097 |
115.097 - 115.612 |
|
Low:
|
108.375 - 109.266 |
109.266 - 109.989 |
|
Close:
|
109.018 - 110.331 |
110.331 - 111.398 |
|
Technical analysis |
as of: 2020-06-03 4:31:37 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 148.63 One year: 173.60 |
| Support: |
Support1: 97.44 Support2: 79.01 |
| Resistance: |
Resistance1: 127.25 Resistance2: 148.63 |
| Pivot: |
117.40  |
| Moving Average: |
MA(5): 114.03 MA(20): 112.10 
MA(100): 87.37 MA(250): 92.35 |
| MACD: |
MACD(12,26): 6.90 Signal(9): 8.77 |
| Stochastic oscillator: |
%K(14,3): 46.54 %D(3): 58.81 |
| RSI: |
RSI(14): 54.34 |
| 52-week: |
High: 127.25 Low: 56.82 Change(%): 21.1 |
| Average Vol(K): |
3-Month: 23688 10-Days: 17689 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.MDGL has closed above bottom band by 8.5%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 07 May 2020
Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights - GlobeNewswire
Sun, 10 May 2020
Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)? - Yahoo Finance
Mon, 11 May 2020
Oppenheimer Gives a Buy Rating to Madrigal Pharmaceuticals (MDGL) - Smarter Analyst
Thu, 28 May 2020
We Think Madrigal Pharmaceuticals (NASDAQ:MDGL) Can Afford To Drive Business Growth - Yahoo Finance
Tue, 05 May 2020
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL - Yahoo Finance
Wed, 13 May 2020
Is A Downturn Overdue? Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), DiamondRock Hospitality Company (NYSE:DRH)? - State Reviewer
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
15 |
| Shares Float (M) |
6 |
|
% Held by Insiders
|
10.80 |
|
% Held by Institutions
|
97.90 |
|
Shares Short (K)
|
3,390 |
|
Shares Short P. Month (K)
|
2,910 |
Stock Financials |
|
EPS
|
-6.810 |
|
EPS Est This Year
|
-2.670 |
|
EPS Est Next Year
|
-3.560 |
|
Book Value (p.s.)
|
24.980 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-16.1 |
|
Return on Equity (ttm)
|
-24.6 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-7.430 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-66 |
|
Levered Free Cash Flow (M)
|
-36 |
Stock Valuations |
|
PE Ratio
|
-16.20 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.42 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-25.93 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
